Skip to main content

Advertisement

SpringerLink
Log in

The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O’Brien SG, Druker BJ (2017) Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med 376(10):917–927. https://doi.org/10.1056/NEJMoa1609324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dahlen T, Edgren G, Lambe M, Hoglund M, Bjorkholm M, Sandin F, Sjalander A, Richter J, Olsson-Stromberg U, Ohm L, Back M, Stenke L (2016) Cardiovascular events associated with use of tyrosine kinase inhibitors in chronic myeloid leukemia: a population-based cohort study. Ann Intern Med 165(3):161–166. https://doi.org/10.7326/m15-2306

    Article  PubMed  Google Scholar 

  3. Sukegawa M, Wang X, Nishioka C, Pan B, Xu K, Ohkawara H, Hamasaki Y, Mita M, Nakamura K, Okamoto M, Shimura H, Ohta M, Ikezoe T (2017) The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1beta in vascular endothelium in association with downregulation of miR-3p. Leuk Res 58:83–90. https://doi.org/10.1016/j.leukres.2017.05.0057

    Article  CAS  PubMed  Google Scholar 

  4. Breccia M, Molica M, Zacheo I, Serrao A, Alimena G (2015) Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment. Ann Hematol 94(3):393–397. https://doi.org/10.1007/s00277-014-2231-9

    Article  CAS  PubMed  Google Scholar 

  5. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331(7):417–424. https://doi.org/10.1056/nejm199408183310701

    Article  CAS  PubMed  Google Scholar 

  6. Biasucci Luigi M, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi Antonio G, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94(5):874–877. https://doi.org/10.1161/01.CIR.94.5.874

    Article  Google Scholar 

  7. Leitinger N (2003) Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 14(5):421–430

    Article  CAS  PubMed  Google Scholar 

  8. Van Tassell BW, Varma A, Salloum FN, Das A, Seropian IM, Toldo S, Smithson L, Hoke NN, Chau VQ, Robati R, Abbate A (2010) Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice. J Cardiovasc Pharmacol 55(2):117–122. https://doi.org/10.1097/FJC.0b013e3181c87e53

    Article  CAS  PubMed  Google Scholar 

  9. Liu SJ, Zhou W, Kennedy RH (1999) Suppression of beta-adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes. Am J Phys 276(1):H141–H148. https://doi.org/10.1152/ajpheart.1999.276.1.H141

    Article  CAS  Google Scholar 

  10. Ridker PM, Everett BM, Thuren T, JG MF, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, JJP K, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, PRF R, RPT T, Libby P, Glynn RJ, Group CT (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119–1131. https://doi.org/10.1056/NEJMoa1707914

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by Grant-in-Aid for Scientific Research

Author information

Authors and Affiliations

  1. Department of Hematology, Fukushima Medical University, Fukushima, 960-1295, Japan

    Hirotaka Mori, Masahiko Fukatsu, Takahiro Sano, Hiroshi Takahashi, Kayo Harada, Satoshi Kimura, Hiroshi Ohkawara & Takayuki Ikezoe

  2. Department of Hematology, Aizu Medical Center, Fukushima, 969-3492, Japan

    Masumi Sukegawa & Masatsugu Ohta

  3. Department of Hematology, Shirakawa Kosei General Hospital, Shirakawa, Fukushima, 961-0005, Japan

    Kenichi Nakamura, Masayuki Mita & Tomiyoshi Saito

  4. Department of Hematology, Iwaki City Medical Center, Fukushima, 973-8555, Japan

    Yoichi Hamazaki

Authors
  1. Hirotaka Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masumi Sukegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahiko Fukatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takahiro Sano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kayo Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Satoshi Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroshi Ohkawara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kenichi Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masayuki Mita
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tomiyoshi Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yoichi Hamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Masatsugu Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Takayuki Ikezoe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takayuki Ikezoe.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mori, H., Sukegawa, M., Fukatsu, M. et al. The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study. Ann Hematol 99, 359–361 (2020). https://doi.org/10.1007/s00277-019-03896-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03896-4

Search

Navigation